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Abstract. Human and veterinary pharma-
ceutical compounds are a source of increasing 
environmental concern because they are used in 
large quantities and their physical and chemical 
properties make them likely to be transported into 
hydrologic systems, where their effects on human 
health and aquatic ecosystems generally are 
unknown. The U.S. Geological Survey (USGS) 
and Centers for Disease Control and Prevention 
(CDC) began a study to determine the occurrence 
of selected pharmaceuticals in treated effluent 
discharged upstream of drinking-water intakes, in 
raw drinking water, and in finished drinking water 
in the upper Chattahoochee River watershed in 
Metropolitan Atlanta. Water samples were 
collected at 11 sampling sites once per month 
during low-flow conditions from July–September 
1999. Two research analytical methods, recently 
developed or modified by the USGS Toxics 
Program, were used to quantify prescription and 
nonprescription pharmaceuticals, including 
antibiotics, at parts per billion (ppb) and sub-ppb 
concentrations in filtered water samples. 
The number of pharmaceuticals detected by site 
type decreased from 16 in treated wastewater-
effluent samples, to 10 in raw-water samples from 
drinking-water intakes, to three in finished-
drinking-water samples. Four prescription  
pharmaceuticals detected were dilitiazem, 
dehydronifedipine, metformin, and gemfibrozil. 
Five nonprescription pharmaceuticals detected 
were caffeine, 1,7-dimethyl xanthine, cotinine, 
cimetidine, and acetominophen. Eight antibiotics 
detected were trimethoprim, sulfamethazine, 
sulfamethoxazole, sulfadimethoxine, 
erythromycin-H20, roxithromycin, lincomycin, 
and enrofioxacin. Seven prescription and 
nonprescription pharmaceuticals and fourteen 
antibiotics were analyzed for, but were not 
detected. The only three pharmaceuticals detected 
in finished-drinking-water samples—caffeine, 
cimetidine, and acetominophen—are widely used 
nonprescription pharmaceuticals. The detection of 
antibiotics in raw drinking water is of particular 
concern because the presence of these chemicals in 
the environment may lead to the development of 
resistant bacterial strains, thus diminishing the 
therapeutic effectiveness of antibiotics. The 
combination of the detection of numerous 
prescription and nonprescription pharmaceutical 
compounds in treated effluent, raw drinking water, 
and finished drinking water; and the absence of 
pharmaceutical manufacturing facilities, suggests 
that human usage of pharmaceuticals is one source 
of these compounds in water resources within the 
upper Chattahoochee River watershed. 
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